Learn hidden causes like hormones, stress, and nutrient deficiencies
Evidence has recently revealed that GLP-1RAs inhibit cardiac hypertrophy by upregulating GLP-1R expression and activating the AMPK/mechanistic target of the rapamycin (mTOR) signaling pathway [78]
Retatrutides triple agonist activity, targeting GLP-1, GIP, and glucagon receptors, enhances both weight loss and metabolic improvements beyond what is typically observed with GLP-1-only therapy
In the Phase 2 clinical trial, obese patients treated with a 12-milligram dose for 48 weeks experienced an average weight reduction of 24.2% (approximately 58 pounds/26.2 kilograms), significantly better than the 2.1% reduction in the placebo group
Still water is a better choice, especially in the first three months
The net effect is simple: After weight loss, people are hungrier, feel less satisfied after eating and burn fewer calories than expected